ArticleThe American journal of case reports2026
Diagnosis of Dual c- and p-ANCA Vasculitis Following SARS-CoV-2 Infection: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Anti-neutrophil cytoplasmic antibodies (ANCAs) are associated with a group of small-vessel vasculitides collectively known as ANCA-associated vasculitis (AAV), which can lead to rapidly progressive glomerulonephritis and multisystem involvement. In addition to other autoimmune diseases, AAV has been increasingly reported following SARS-CoV-2 infection. CASE REPORT We present the case of a 70-year-old woman with a past medical history of atrial fibrillation, sick sinus syndrome, breast cancer, gastroesophageal reflux disease, and anxiety, who developed a rare phenomenon of dual ANCA-positive pauci-immune glomerulonephritis following coronavirus disease 2019 (COVID-19). She initially presented with refractory sinusitis and a persistent cough. Over 5 months, she developed iron-deficiency anemia and, eventually, a rapid decline in renal function. Serologic testing revealed dual positivity for anti-proteinase 3 (PR3, c-ANCA) and anti-myeloperoxidase (MPO, p-ANCA). Renal biopsy confirmed pauci-immune glomerulonephritis. She was ultimately diagnosed with granulomatosis with polyangiitis (GPA). CONCLUSIONS This case highlights a potential post-infectious autoimmune phenomenon triggered by SARS-CoV-2 and underscores the importance of considering AAV in patients with unexplained systemic symptoms and renal dysfunction after COVID-19. Furthermore, the mechanism of AAV seroconversion and disease progression may be linked to the ability of SARS-CoV-2 to induce the formation of neutrophil extracellular traps (NETs) through both direct viral-neutrophil interactions and cytokine-mediated inflammation. Our findings contribute to the growing body of evidence linking viral infections to the emergence of autoimmune vasculitis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.